Credence Genomics (Sri Lanka) is a clinical genomics company specializing in next-generation sequencing (NGS)-based infectious disease diagnostics. Its pathogen detection solutions integrate advanced metagenomic sequencing, bioinformatics, and machine learning to provide comprehensive and precise identification of bacterial, fungal, and viral pathogens. By delivering rapid, clinically actionable insights, Credence Genomics supports confident decision-making across critical care, diagnostics, and infectious disease surveillance.